Group One Trading
HCAT icon

Group One Trading’s Health Catalyst HCAT Stock Holding History

Group One Trading’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-86
Closed -$162 – 8064
2025
Q4 		$206 Hold
86
– – ﹤0.01% 7885
2025
Q3 		$245 Sell
86
-2,000
-96% -$6.85K ﹤0.01% 8205
2025
Q2 		$7.86K Hold
2,086
– – ﹤0.01% 6865
2025
Q1 		$9.45K Sell
2,086
-2,274
-52% -$12K ﹤0.01% 6295
2024
Q4 		$30.8K Buy
4,360
+2,260
+108% +$18K ﹤0.01% 5414
2024
Q3 		$17.1K Buy
2,100
+2,000
+2,000% +$14.5K ﹤0.01% 5317
2024
Q2 		$639 Buy
+100
New +$642 ﹤0.01% 6426
2022
Q4 		– Sell
-11,933
Closed -$115K – 7569
2022
Q3 		$116K Buy
+11,933
New +$158K ﹤0.01% 4642
2020
Q2 		– Sell
-538
Closed -$14.9K – 5932
2020
Q1 		$14K Buy
+538
New +$16.4K ﹤0.01% 4420

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's HCAT Position: Q1 2026 in Review

Group One Trading sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 86 shares — an estimated $162 sold.

Group One Trading first reported a position in HCAT in Q1 2020 and held it in 9 quarters. The position peaked at $116K in Q3 2022. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Group One Trading reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 86 Health Catalyst shares in Q1 2026, an estimated $162.
  • Group One Trading first reported a position in Health Catalyst in Q1 2020 and held it in 9 quarters.
  • Group One Trading's Health Catalyst position peaked at $116K in Q3 2022.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.